Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/15/2000CN1273531A Chromium/biotin treatment of type II diabetes
11/15/2000CN1273530A Method to potentiate intraveneous estramustin phosphate
11/15/2000CN1273529A Vitronection receptor antagonist
11/15/2000CN1273528A Novel heterocyclic analogs of diphenylethylene compounds
11/15/2000CN1273527A Taste masked pharmaceutical compositions
11/15/2000CN1273239A (Poly) thia acetylenic acid and it derivative, composite containing them and its application
11/15/2000CN1273124A Powder prepared with colophony, realgar and 'Huangdan'
11/15/2000CN1273119A Composite safflower oil preparation and medicine containing it
11/15/2000CN1273113A Medicine prepared from bolostemmatoside B for preventing and curing tumor
11/15/2000CN1273111A Ointment for treating skin tinea
11/15/2000CN1273101A Thermal picking for recovery of hyperosteogeny and protrusion of intervertebral disc
11/15/2000CN1273099A Exterior-applied medicine for treating scald and its preparing process
11/15/2000CN1273095A Exterior-applied medicine for treating dermatopathy and its preparing process
11/15/2000CN1273094A Anticancer medicine
11/15/2000CN1273093A Hypoglycemix Xinxuekang and itspreparing process
11/15/2000CN1273092A Water-soluble powdered quinolone medicines
11/15/2000CN1273091A Slowly releasing piperazine ferulate
11/15/2000CN1273088A Amino substituted hydroxy-diphenylone as light stability ultraviolet fitering agent used in cosmetic and pharmaceutical preparation
11/15/2000CN1273032A Water-soluble aromatic xibitane iodine
11/15/2000CN1058499C 16-substituted-4-aza-androstane 5-alpha-reductase isoazyne 1 inhibitors
11/15/2000CN1058496C Process for isolating or purifying cefonicid and process for preparing salts thereof
11/15/2000CN1058495C Polycyclic systems compound and derivatives thereof as neurotransmitter release enhancers useful in the treatment of cognitive disordes and medicine containing them and its use
11/15/2000CN1058494C New diosmetin compound, process for their preparation and pharmaceutial compositions containing them
11/15/2000CN1058487C 1,5-benzodiazepine derivatives having CCK antagoistic or agonistic activity
11/15/2000CN1058407C Medicine for treatment of gastropathy
11/15/2000CN1058392C Disinfecting anti-inflammatory pill and preparing method
11/15/2000CN1058391C Prepared anthracene ring glucosides anticancer solution for injection
11/15/2000CN1058390C Use of compound of benzo-thiophenes
11/15/2000CN1058389C Use of compound of benzo-thiophenes
11/15/2000CN1058388C Stable freeze dried polyhematoporphyrin ether/ester composition
11/14/2000US6147275 Corticotropin releasing factor receptor 1-deficient mice
11/14/2000US6147262 Antiproliferative agents
11/14/2000US6147255 Topical and systemic treatment of dermatological complaints associated with keratinization disorder which has effect on differentiation and on proliferation
11/14/2000US6147250 Treating diseases mediated by vascular cell adhesion molecule-1, including cardiovascular and inflammatory diseases; succinobucol
11/14/2000US6147232 Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
11/14/2000US6147230 Amino acid dysiherbaine
11/14/2000US6147224 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/14/2000US6147223 Lactacystin analogs
11/14/2000US6147214 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
11/14/2000US6147212 Proline-naphthylalanine dipeptide amidated with an acyl derivative on the n-terminus and a 4-phenyl-1-piperazinyl derivative on the carboxyl terminus; neurokinin (tachykinin) antagonist
11/14/2000US6147207 Bonding polyether chain ends to alcohol-reactive moieties of a porphyrin, then partially hydrogenating the porphyrin to yield a chlorin
11/14/2000US6147200 2'-O-acetamido modified monomers and oligomers
11/14/2000US6147199 Viricides
11/14/2000US6147197 6-O-substituted erythromycin ketolides having antibacterial activity
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147123 Administering butylated hydroxytoluene to treat hepatic fibrosis, hepatitis c and other liver disorders
11/14/2000US6147122 Oil in water emulsion used for injection with antimicrobial growth agent; prevents growth of escherchia, candida, pseudomonas, and staphylococcus
11/14/2000US6147121 Skin toning by stimulating collagen synthesis/proliferation of dermal fibroblasts
11/14/2000US6147120 Synergistic antimicrobial skin washing compositions
11/14/2000US6147119 Biphenyl compounds and use thereof as oestrogenic agents
11/14/2000US6147117 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/14/2000US6147116 Polyaromatic antiviral compositions
11/14/2000US6147115 Antitumor compositions and methods of treatment
11/14/2000US6147114 Highly water-soluble metalloproteinase inhibitors
11/14/2000US6147112 Administering to treat sexual and vascular disorders and diabetes
11/14/2000US6147111 Kidney, brain, and cardiovascular disorders; vasodilation
11/14/2000US6147110 Heterocyclic compounds
11/14/2000US6147109 Treating impotency; brain, cardiovascular, respiratory system and gastrointestinal disorders
11/14/2000US6147108 Administering an effective amount of a gastrointestinal lipase inhibitor, such as, tetrahydrolipstatin
11/14/2000US6147107 Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
11/14/2000US6147103 Extremely low residual solvent content
11/14/2000US6147102 Topical aqueous gel suitable for relieving sympathetically maintained peripheral neuropathic pain syndrome
11/14/2000US6147100 Antiinflammatory agents
11/14/2000US6147099 Oxazolidinedione derivatives, their production and use
11/14/2000US6147097 Imidazole derivatives as anti-HIV agents
11/14/2000US6147096 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
11/14/2000US6147095 Administering combination of tipranavir and ritonavir for treatment of hiv
11/14/2000US6147094 Chelating agents and their metal chelates used to reduce cardiotoxic side-effects
11/14/2000US6147093 Optically pure (+) isomer of norcisapride used for treatment of disorders caused by gastrointestinal motility dysfunction
11/14/2000US6147092 Method for inhibiting estrogen-dependent cancer
11/14/2000US6147090 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147089 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147087 Use of 1,2-Bridged 1,4-dihydropyridines as medicaments
11/14/2000US6147086 Method employing imiquimod cream for treatment of topical sarcoidosis on equine
11/14/2000US6147084 Morphinan derivative; useful preventive and therapeutic agents of schemic brain disorders, brain nerve cell disorders and dementia
11/14/2000US6147082 Chalcones having antiproliferative activity
11/14/2000US6147081 Ophthalmic solution
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147079 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
11/14/2000US6147077 2R,4S-hydroxyitraconazole isomers
11/14/2000US6147076 Analogues of N-acetylardeemin, method of preparation and uses thereof
11/14/2000US6147075 Analgesics; psychological disorders
11/14/2000US6147073 Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase inhibitors
11/14/2000US6147072 Administering antidepressant and serotonin reuptake inhibitor
11/14/2000US6147070 Screening; controlling iron comcemtration in blood
11/14/2000US6147069 Effects of 17α-dihydroequilenin on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals
11/14/2000US6147068 Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
11/14/2000US6147066 Use of antimineralocorticoid compounds against drug withdrawal syndrome
11/14/2000US6147065 14-α, 17-α-C2 bridged norprogesterone derivatives
11/14/2000US6147064 Oral 1α-hydroxyprevitamin D in composition and method for treating psoriasis
11/14/2000US6147063 Therapeutic substituted guanidines
11/14/2000US6147061 Antiarthritic agents; anticancer agents; oral diseases
11/14/2000US6147060 Treatment of carcinomas using squalamine in combination with other anti-cancer agents
11/14/2000US6147059 Accumulation a drug in skin
11/14/2000US6147056 Therapy for psoriasis
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6147054 Composition for cosmetic, pharmaceutical or dietetic use based on an amino sugar and/or a polyhydroxylic acid
11/14/2000US6147053 Combination containing growth factors and polyelectrolytes
11/14/2000US6147051 Antiischemic agent
11/14/2000US6146887 DNA expression vectors for use in the gene therapeutic treatment of vascular disorders
1 ... 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 ... 7860